Company record
LeMaitre Vascular, Inc.
1 FDA warning letter since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about LeMaitre Vascular, Inc..
Warning letters
-
DevicesLeMaitre Vascular, Inc.
LeMaitre Vascular's Artegraft graft plant in New Jersey drew an FDA warning letter for water, sterilization and recall-reporting failures.
High risk
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Oct 14 | Class II | LeMaitre Vascular, Inc. Device |
TufTex¿ Over-the-Wire Embolectomy Catheter; Catalog Number: E1651-88; Devices failed in process testing related to the amount of pull force it can sustain prior to the balloon components failing. |
| Mar 25 | Class II | LeMaitre Vascular, Inc. Device |
Artegraft Vascular Graft; REF#: AG740; Labeling mix-up resulting in the incorrect lot outer packaging of product. |